Pooled patient level data are better suited than study level data to investigate the link between dipeptidyl peptidase-4 inhibitors and the risk of heart failure in type 2 diabetes.
Patel T, Tesfaldet B, Gandotra C; Meta-AnalyTical Interagency Group (MATIG) (Keith Burkhart, MD; Henry Chang, MD; Jue Chen, MS, PhD; Sean Coady, MS; Lawton Cooper, MD; Gyorgy Csako, MD; Michelle Fennessy, RN, PhD; Jerome Fleg, MD; Ahmed Hasan, MD, PhD, FACC; Ruth Kirby, BS, RN; Eileen Navarro Almario, MD, MS, FACP; Frank Pucino, PharmD, MPH; Subha Raman, MD; Yves Rosenberg, MD, MPH; George Sopko, MD; Helena Sviglin, MPH; Robert Wesley, PhD.
Patel T, et al. Among authors: gandotra c.
BMJ. 2016 May 24;353:i2920. doi: 10.1136/bmj.i2920.
BMJ. 2016.
PMID: 27220716
No abstract available.